Free the Data’s first move: Opening data for breast cancer research | VentureBeat

"For decades, one company owned the data for people tested for a gene that is linked to ovarian and breast cancer. Many scientists believe that the patenting of this gene stunted medical innovation and delayed discoveries that could have helped us understand and more effectively treat various forms of cancer. But in June of this year, the Supreme Court issued a landmark ruling to open up the data to researchers and declared that human genes should not be patented. At the center of the debate was a biotech giant called Myriad Genetics, which had patented its discovery that two genes — BRCA 1 and BRCA 2 — are associated with breast and ovarian cancer ... It was a huge victory for the research community, many members of which believe that the decision was about 20 years overdue. In the immediate aftermath of the Supreme Court’s decision, a group of health providers joined forces to launch an initiative called Free the Data.  Free the Data opened its medical dataset to the public this week. The goal is to accelerate research and improve our understanding of the root causes of cancer ... Free the Data is run by a consortium of health organizations, including the Genetic Alliance, UCSF, and Capricity.  Patients are asked to upload their data and for information about their genetic mutations. They can then set their own preferences for how this data can be shared. Privacy is clearly a potential concern for some patients, but Free the Data proponents are hoping to mitigate fears by setting clear guidelines.  Genetic Alliance chief Sharon Terry is firmly against any one corporation owning or patenting genes. She says the Free the Data initiative will benefit minority communities with rare genetic mutations (it’s still not clear whether these mutations are associated with cancer) and physicians who could use it to make better treatment recommendations for their patients ..."